IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 375 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $250,263 | +9.9% | 5,251 | 0.0% | 0.00% | +50.0% |
| Q1 2024 | $227,631 | -13.0% | 5,251 | +1.6% | 0.00% | -33.3% |
| Q4 2023 | $261,550 | +11.5% | 5,170 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $234,511 | +11.5% | 5,170 | +0.9% | 0.00% | 0.0% |
| Q2 2023 | $210,279 | -6.5% | 5,125 | +0.6% | 0.00% | -40.0% |
| Q3 2022 | $225,000 | +10.8% | 5,092 | +0.3% | 0.01% | 0.0% |
| Q2 2021 | $203,000 | -11.0% | 5,078 | 0.0% | 0.01% | -54.5% |
| Q1 2021 | $228,000 | -22.7% | 5,078 | -2.6% | 0.01% | -26.7% |
| Q4 2020 | $295,000 | +19.4% | 5,212 | 0.0% | 0.02% | -21.1% |
| Q3 2020 | $247,000 | +0.4% | 5,212 | 0.0% | 0.02% | -20.8% |
| Q1 2020 | $246,000 | -21.9% | 5,212 | 0.0% | 0.02% | -20.0% |
| Q4 2019 | $315,000 | +1.0% | 5,212 | 0.0% | 0.03% | -11.8% |
| Q3 2019 | $312,000 | -31.4% | 5,212 | -26.4% | 0.03% | -30.6% |
| Q2 2019 | $455,000 | -22.0% | 7,078 | -1.5% | 0.05% | -32.9% |
| Q1 2019 | $583,000 | – | 7,184 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |